Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,770 results for "Product Liability Law & Strategy"...

Drug & Device News
June 22, 2010
A roundup of recent developments.
NJ Supreme Court Extends Long-Arm Jurisdiction to Foreign Manufacturers
June 22, 2010
On Feb. 2 of this year, the Supreme Court of New Jersey held that a foreign manufacturer of an industrial recycling machine is subject to New Jersey's long-arm jurisdiction under the stream-of-commerce theory. This has broad implications.
Third Circuit Rejects Defective Sperm As Basis for Product Liability Suit
June 22, 2010
On April 1, the Third Circuit upheld a June 2009 decision by U.S. District Judge Thomas N. O'Neill Jr. that rejected claims by a mother and her daughter who suffers from Fragile X syndrome, a mutation known to cause a group of serious maladies.
Practice Tip: Admissibility of Expert Opinions
June 22, 2010
The purpose of this article is to provide an update of the themes and factors that were important to courts in 2009 in reaching their decisions on the admissibility of expert witness opinions.
When Is an Expert Not an Expert?
June 22, 2010
The defense of a pharmaceutical or medical device product liability case often turns on the testimony of the core treating physicians. As defense counsel, we often are left holding our breath waiting to see how the physicians testify at their depositions or at trial. So do the plaintiffs.
Physician and Pharmaceutical Industry Relationships
June 22, 2010
According to a national survey of doctors published in <i>The New England Journal of Medicine</i>, 94% of physicians have "a relationship" with the pharmaceutical, medical device or related industries. A research firm recently estimated that drug companies spend over $20 billion annually marketing directly to physicians. With statistics like these, it is not surprising that the public is becoming concerned that these ties may influence how medications are developed, marketed and prescribed.
What Works and What Doesn't in Legal Advertising
June 01, 2010
In advertising, it's amazing what works and what doesn't work. It isn't always what you think it is.
Antitrust Issues in IP Settlements
May 27, 2010
This article discusses some common IP settlement terms that may give rise to antitrust liability.
Ten Issues to Consider in Launching a Social Media Presence
May 27, 2010
Intellectual property and advertising issues have emerged in the forefront of social media law. This article provides a brief look at 10 of these issues.
Off-Label Marketing and the First Amendment
May 27, 2010
Pharmaceutical and medical device manufacturers have argued that FDA restrictions on off-label promotion infringe their First Amendments rights. While First Amendment defenses are difficult, two recent cases have placed this issue back in the spotlight.

MOST POPULAR STORIES

  • The FTC Gets Into the College Athlete NIL Game
    As national champions are crowned in men's and women's basketball, hundreds of thousands of college athletes are entering the influencer marketplace for the first time and now find themselves attractive candidates in the fast growing influencer marketing arena. With influencer marketing potentially providing a 5x return on investment, many brands are eager to get into the industry, but it doesn't come without risks as the FTC Commissioner is taking a closer look at the use of influencers for marketing.
    Read More ›
  • The Roadmap of Litigation Analytics
    Litigation analytics can be considered a roadmap of sorts — an important guide to ensure the legal professional arrives at the correct litigation strategy or business plan. However, like roadmaps, litigation analytics will only be useful if it's based on data that is complete and accurate.
    Read More ›